CMPX
Price
$1.50
Change
-$0.01 (-0.66%)
Updated
Dec 24 closing price
83 days until earnings call
RIGL
Price
$16.44
Change
-$0.71 (-4.14%)
Updated
Dec 24 closing price
Ad is loading...

CMPX vs RIGL

Header iconCMPX vs RIGL Comparison
Open Charts CMPX vs RIGLBanner chart's image
Compass Therapeutics
Price$1.50
Change-$0.01 (-0.66%)
Volume$134.47K
CapitalizationN/A
Rigel Pharmaceuticals
Price$16.44
Change-$0.71 (-4.14%)
Volume$490.88K
CapitalizationN/A
CMPX vs RIGL Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. RIGL commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Buy and RIGL is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 26, 2024
Stock price -- (CMPX: $1.50 vs. RIGL: $16.44)
Brand notoriety: CMPX and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 29% vs. RIGL: 206%
Market capitalization -- CMPX: $206.38M vs. RIGL: $289.59M
CMPX [@Biotechnology] is valued at $206.38M. RIGL’s [@Biotechnology] market capitalization is $289.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, CMPX is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 5 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а -1.96% price change this week, while RIGL (@Biotechnology) price change was -10.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CMPX is expected to report earnings on Mar 19, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($290M) has a higher market cap than CMPX($206M). RIGL YTD gains are higher at: 13.379 vs. CMPX (-3.846). RIGL has higher annual earnings (EBITDA): 13.7M vs. CMPX (-53.58M). CMPX has more cash in the bank: 135M vs. RIGL (61.1M). CMPX has less debt than RIGL: CMPX (6.88M) vs RIGL (60.2M). RIGL has higher revenues than CMPX: RIGL (157M) vs CMPX (850K).
CMPXRIGLCMPX / RIGL
Capitalization206M290M71%
EBITDA-53.58M13.7M-391%
Gain YTD-3.84613.379-29%
P/E RatioN/A60.89-
Revenue850K157M1%
Total Cash135M61.1M221%
Total Debt6.88M60.2M11%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXRIGL
RSI
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 30 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICSSX16.950.14
+0.83%
VY® Columbia Small Cap Value II S
JHDAX18.770.11
+0.59%
JPMorgan Hedged Equity 2 A
HFECX42.720.10
+0.23%
Janus Henderson European Focus C
WBIGX26.500.02
+0.08%
William Blair International Growth N
GGLCX10.23N/A
N/A
Gabelli International Small Cap C

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-0.66%
TRDA - CMPX
44%
Loosely correlated
+0.57%
ABOS - CMPX
41%
Loosely correlated
+1.13%
ABCL - CMPX
40%
Loosely correlated
+1.03%
IPSC - CMPX
40%
Loosely correlated
+0.49%
FHTX - CMPX
40%
Loosely correlated
+1.83%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with RCUS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-4.14%
RCUS - RIGL
39%
Loosely correlated
-0.31%
NTLA - RIGL
37%
Loosely correlated
-0.41%
AGIO - RIGL
37%
Loosely correlated
-3.28%
WVE - RIGL
36%
Loosely correlated
+2.21%
ACLX - RIGL
36%
Loosely correlated
+1.03%
More